Genetic testing using stored or new cancer samples
Part of Blood & lymphatic, Cancer clinical trials.
This study collects and analyzes genetic information from tissue or blood samples to help understand cancer and related inherited (family) risk. It may involve testing results being shared with you or your care team, depending on what samples are available.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be able to give informed consent (or have consent arranged through the study process).
- You need a sample from a procedure like surgery, endoscopy, biopsy, or a blood test (including liquid biopsy) that can be stored for future research.
- You may join Part A if you already have stored samples from a past procedure that haven’t been used for this specific research consent yet.
- To continue to Part C, you must be cared for at MSK or an affiliated site, or have previously seen an MSK doctor, and you must successfully consent to Part A.
- If you have no personal cancer history, you may only qualify if you have higher cancer risk due to family history, genetic carrier status, known gene markers, or certain exposures/lifestyle factors.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at DNA (genetic information) from people and families who may have an inherited risk for cancer. It aims to find new genetic markers that can help explain cancer risk and guide future care.
This study looks at the genetic information (DNA) from your blood and from saved tumor tissue to better understand certain cancers, especially rare cancers with a poor outlook. It may help researchers learn why these cancers behave the way they do and guide future treatments.
This study collects family and medical history to better understand inherited causes of blood cancers (like lymphoma) and related conditions. It may help researchers build genetic findings that could improve how families understand their risk and future care.
This study uses gene testing on stored tumor tissue (and a blood sample) to help doctors recommend treatment options that may fit your tumor’s specific changes. It may also help avoid certain medicines and share your de-identified data with other researchers.
This study looks at cancer-related inherited gene changes using blood samples. It may help patients and doctors understand cancer risk and guide treatment planning, especially across different ethnic communities.
This trial uses special lab tests to look for tumor “molecular fingerprints” in your tumor or blood sample. The goal is to help your care team choose more personalized treatment options based on those results.
Hear when a new Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.